SecurityUNIT / Uniti Group Inc. (20341J104)
Institutional Owners145 (138 N-Q Owners)
Institutional Shares3,208,103 - 1.83% (ex. N-Q)
Common Shares Outstanding175,428,468 shares (as of 2017-12-31)
Institutional Value$ 70,024,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Uniti Group Inc. (NASDAQ:UNIT) has 145 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,208,103 shares. Largest shareholders include Toscafund Asset Management LLP, Norges Bank, Group One Trading, L.p., Hbk Investments L P, Group One Trading, L.p., Monroe Bank & Trust/mi, Simplex Trading, Llc, and Alpha Omega Wealth Management LLC.

Uniti Group Inc. (NASDAQ:UNIT) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Prev Value
Current Value
2017-10-30 N-Q Investment Managers Series Trust Ii (see advisory)
2017-11-02 13F-HR/A-1 Advisor Group, Inc. 9,008 0 -100.00 229 0 -100.00
2018-02-23 N-Q Sterling Capital Funds (see advisory)
2017-11-29 N-Q Virtus Variable Insurance Trust (see advisory)
2017-12-29 N-Q Palmer Square Opportunistic Income Fund (see advisory)
2017-09-27 N-Q Ab Unconstrained Bond Fund, Inc. (see advisory)
2017-11-20 N-Q Dreyfus Variable Investment Fund (see advisory)
2017-12-29 N-Q Oppenheimer Senior Floating Rate Fund (see advisory)
2017-09-28 N-Q Prudential Investment Portfolios, Inc. 10 (see advisory)
2018-02-28 N-Q Goldman Sachs Trust (see advisory)
2017-10-30 N-Q Natixis Funds Trust Ii (see advisory)
2017-12-29 N-Q Virtus Etf Trust Ii (see advisory)
2017-11-29 N-Q Advanced Series Trust (see advisory)
2018-02-28 N-Q Virtus Opportunities Trust (see advisory)
2017-10-30 N-Q John Hancock Bond Trust (see advisory)
2017-11-13 13F-HR/A-1 NORGES BANK 1,357,166 1,357,166 0.00 39,222 40,715 3.81
2017-09-27 N-Q Dnp Select Income Fund Inc (see advisory)
2018-03-01 N-Q Optimum Fund Trust (see advisory)
2018-02-26 N-Q Blackrock Funds Ii (see advisory)
2017-10-27 N-Q Western Asset Funds Inc (see advisory)
2017-09-29 N-Q Harbor Funds (see advisory)
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Call 25,800 28,800 11.63 378 512 35.45
2017-09-28 N-Q Delaware Pooled Trust (see advisory)
2017-09-27 N-Q Pioneer High Yield Fund (see advisory)
2018-02-27 N-Q Pioneer High Income Trust (see advisory)
2018-03-01 N-Q First Investors Equity Funds (see advisory)
2017-11-22 N-Q Spdr Series Trust (see advisory)
2018-03-01 N-Q Nuveen Investment Trust Iii (see advisory)
2017-11-29 N-Q Fs Series Trust (see advisory)
2017-11-28 N-Q Driehaus Mutual Funds (see advisory)
2017-11-29 N-Q Vanguard Montgomery Funds (see advisory)
2017-09-22 N-Q Western Asset Middle Market Debt Fund Inc. (see advisory)
2017-09-28 N-Q Mainstay Funds Trust (see advisory)
2018-02-28 N-Q Virtus Equity Trust (see advisory)
2017-11-29 N-Q Aim Growth Series (invesco Growth Series) (see advisory)
2017-11-14 N-Q Wright Managed Equity Trust (see advisory)
2017-11-29 N-Q Gamco Global Series Funds, Inc (see advisory)
2017-09-27 N-Q Pioneer Diversified High Income Trust (see advisory)
2018-02-28 N-Q Seasons Series Trust (see advisory)
2017-11-29 N-Q Hc Capital Trust (see advisory)
2017-09-28 N-Q Mainstay Funds (see advisory)
2018-02-28 N-Q Fidelity Central Investment Portfolios Llc (see advisory)
2017-11-29 N-Q Vanguard Institutional Index Funds (see advisory)
2017-12-29 N-Q Oppenheimer Senior Floating Rate Plus Fund (see advisory)
2018-02-28 N-Q Fidelity Summer Street Trust (see advisory)
2018-03-01 N-Q Oppenheimer Master Loan Fund, Llc (see advisory)
2017-11-28 N-Q Pax World Funds Series Trust I (see advisory)
2017-09-29 N-Q Ishares U.s. Etf Trust (see advisory)
2017-09-20 N-Q Amg Funds Iv (see advisory)
2017-09-28 N-Q VANGUARD WINDSOR FUNDS (see advisory)
2018-02-16 13F-HR/A-1 Commonwealth Equity Services, Inc 21,520 0 -100.00 547 0 -100.00
2017-11-24 N-Q Transamerica Etf Trust (see advisory)
2017-09-25 N-Q Reaves Utility Income Fund (see advisory)
2018-01-11 N-Q Managed Portfolio Series (see advisory)
2017-12-27 N-Q Advisors' Inner Circle Fund Ii (see advisory)
2018-02-28 N-Q VANGUARD HORIZON FUNDS (see advisory)
2017-09-29 N-Q Neuberger Berman High Yield Strategies Fund Inc. (see advisory)
2017-11-29 N-Q Mutual Fund & Variable Insurance Trust (see advisory)
2018-02-14 13F-HR HBK INVESTMENTS L P Call 100,000 100,000 0.00 1,466 1,779 21.35
2018-02-26 N-Q Alliancebernstein Global High Income Fund Inc (see advisory)
2017-10-27 N-Q Western Asset Investment Grade Defined Opportunity Trust Inc. (see advisory)
2017-10-30 N-Q Delaware Investments Dividend & Income Fund, Inc (see advisory)
2017-09-26 N-Q Wilmington Funds (see advisory)
2017-09-28 N-Q Federated Index Trust (see advisory)
2018-03-01 N-Q Alps Series Trust (see advisory)
2018-02-26 N-Q Allianz Funds Multi-strategy Trust (see advisory)
2017-11-15 N-Q Oppenheimer Etf Trust (see advisory)
2018-02-20 N-Q Dreyfus High Yield Strategies Fund (see advisory)
2018-01-26 N-Q Bny Mellon Funds Trust (see advisory)
2018-01-26 N-Q J.p. Morgan Exchange-traded Fund Trust (see advisory)
2017-09-27 N-Q Pioneer Series Trust Vii (see advisory)
2018-03-01 N-Q Sei Institutional International Trust (see advisory)
2017-09-29 N-Q Global X Funds (see advisory)
2017-10-20 N-Q Strategic Funds, Inc. (see advisory)
2018-02-28 N-Q Sunamerica Income Funds (see advisory)
2017-10-20 N-Q Dreyfus Manager Funds Ii (see advisory)
2018-02-28 N-Q Transparent Value Trust (see advisory)
2017-12-22 N-Q Legg Mason Partners Income Trust (see advisory)
2018-01-26 N-Q Jpmorgan Trust I (see advisory)
2017-09-22 N-Q Western Asset Middle Market Income Fund Inc. (see advisory)
2017-12-28 N-Q Fidelity Salem Street Trust (see advisory)
2017-11-29 N-Q Investment Managers Series Trust (see advisory)
2018-02-12 13F-HR MONROE BANK & TRUST/MI 918 918 0.00 23 23 0.00
2018-02-14 13F-HR Wildcat Capital Management, LLC 410,700 0 -100.00 6,021 0 -100.00
2017-09-27 N-Q Ab High Income Fund Inc (see advisory)
2018-02-06 13F-HR Alpha Omega Wealth Management LLC 19 0
2017-09-20 N-Q Dreyfus Growth & Income Fund Inc. (see advisory)
2018-01-26 N-Q Fidelity Income Fund /ma/ (see advisory)
2017-11-28 N-Q Ancora Trust (see advisory)
2018-03-01 N-Q Oppenheimer Global Strategic Income Fund (see advisory)
2018-02-27 N-Q Vaneck Vectors Etf Trust (see advisory)
2017-12-27 N-Q Delaware Group Income Funds (see advisory)
2017-10-27 N-Q Virtus Global Multi-sector Income Fund (see advisory)
2017-09-29 N-Q Oppenheimer Small Cap Value Fund (see advisory)
2017-09-22 N-Q Nationwide Mutual Funds (see advisory)
2018-01-25 N-Q Ab Portfolios (see advisory)
2018-02-28 N-Q Wisdomtree Trust (see advisory)
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Put 86,200 108,000 25.29 1,264 1,921 51.98
2017-11-14 13F-HR/A-1 UBS Group AG 199,376 0 -100.00 5,066 0 -100.00
2017-11-21 N-Q Dreyfus Investment Portfolios (see advisory)
2017-11-28 N-Q Penn Capital Funds Trust (see advisory)
2017-11-20 N-Q Fqf Trust (see advisory)
2017-09-27 N-Q Etfis Series Trust I (see advisory)
2018-01-24 N-Q Blackrock Funds (see advisory)
2017-11-29 N-Q Gabelli Dividend & Income Trust (see advisory)
2017-09-27 N-Q Flexshares Trust (see advisory)
2018-02-28 N-Q Ishares Trust (see advisory)
2018-02-14 13F-HR Toscafund Asset Management LLP 775,000 1,850,000 138.71 11,362 29,286 157.75
2017-09-27 N-Q Lord Abbett Affiliated Fund Inc (see advisory)
2018-02-26 N-Q TIAA-CREF FUNDS (see advisory)
2017-10-30 N-Q Delaware Group Equity Funds V (see advisory)
2018-01-24 N-Q Capitol Series Trust (see advisory)
2017-11-17 N-Q Lazard World Dividend & Income Fund, Inc. (see advisory)
2017-11-29 N-Q Nuveen S&p 500 Dynamic Overwrite Fund (see advisory)
2017-10-30 N-Q Oppenheimer Global High Yield Fund (see advisory)
2018-03-01 N-Q Resource Real Estate Diversified Income Fund (see advisory)
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2017-11-21 N-Q Meeder Funds (see advisory)
2018-03-01 N-Q Loomis Sayles Funds I (see advisory)
2017-11-29 N-Q Virtus Global Dividend & Income Fund Inc. (see advisory)
2017-09-27 N-Q Duff & Phelps Global Utility Income Fund Inc. (see advisory)
2017-09-20 N-Q Dreyfus Midcap Index Fund Inc (see advisory)
2017-09-15 13F-HR/A-1 ASSETMARK, INC 56 0 -100.00 1 0 -100.00
2018-02-28 N-Q Rydex Series Funds (see advisory)
2018-01-10 13F-HR SIMPLEX TRADING, LLC Call 433 843 94.69 36 44 22.22
2018-01-31 13F-HR/A-1 CANADA PENSION PLAN INVESTMENT BOARD 5,100 0 -100.00 130 0 -100.00
2018-01-30 N-Q Shelton Funds (see advisory)
2018-03-14 N-Q Steward Funds, Inc. (see advisory)
2017-10-27 N-Q Etf Series Solutions (see advisory)
2017-09-26 N-Q Pacer Funds Trust (see advisory)
2018-01-26 N-Q Vanguard Admiral Funds (see advisory)
2018-02-27 N-Q Pioneer Strategic Income Fund (see advisory)
2017-09-28 N-Q Oppenheimer Equity Income Fund (see advisory)
2018-02-27 N-Q Massmutual Premier Funds (see advisory)
2017-10-27 N-Q Virtus Total Return Fund Inc. (see advisory)
2018-02-26 N-Q Ab Bond Fund, Inc. (see advisory)
2018-02-27 N-Q Northern Funds (see advisory)
2017-09-29 N-Q John Hancock Exchange-traded Fund Trust (see advisory)
2018-01-29 N-Q Consulting Group Capital Markets Funds (see advisory)
2017-11-29 N-Q Delaware Group Limited-term Government Funds (see advisory)
2018-02-27 N-Q Blackstone Alternative Investment Funds (see advisory)
2017-11-28 13F-HR/A-1 SHELTON CAPITAL MANAGEMENT 9,408 0 -100.00 239 0 -100.00
2017-10-30 N-Q Delaware Enhanced Global Dividend & Income Fund (see advisory)
2018-01-26 N-Q Fidelity Concord Street Trust (see advisory)
2017-09-29 N-Q Oppenheimer Dividend Opportunity Fund (see advisory)
2017-09-28 N-Q Delaware Group Adviser Funds (see advisory)
2017-11-29 N-Q Gabelli Multimedia Trust Inc. (see advisory)
2018-02-28 N-Q Ivy Funds (see advisory)
2018-03-01 N-Q Sei Institutional Managed Trust (see advisory)
2018-01-22 N-Q Blackrock Debt Strategies Fund, Inc. (see advisory)
2018-02-27 N-Q Massmutual Select Funds (see advisory)
2017-11-29 N-Q Waddell & Reed Advisors Funds (see advisory)
2017-11-28 N-Q Nexpoint Real Estate Strategies Fund (see advisory)

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.


  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( UNIT / Uniti Group Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 20341J104